ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility

Contributed by: PR Newswire

Tags

ST-Pharm-Co

More Like This

SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production

PR Newswire associated0

Tsingke Biotech Hosts 2025 Small Nucleic Acid Therapeutics Roundtable in Beijing

PR Newswire associated0

Tsingke Biotech Participates in TIDES USA 2025, Demonstrates Full-Scale Oligonucleotide Synthesis Capabilities

TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

Olon is ready to host productions in the new facility dedicated to ultra-potent compounds

PR Newswire associated0

SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

PR Newswire associated0

LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus

WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication